Effects of Almonds on Insulin Sensitivity in Prediabetes

Status Completed

Clinical Trial Summary

The goal of this clinical trial is to evaluate the effects of consuming 1.5 oz almonds twice daily on insulin sensitivity and markers of cardiometabolic health in men and women with prediabetes.

Clinical Trial Description

This is a randomized, controlled, two-period crossover study that includes two screening visits, and two 6-week test periods, separated by a 4-week washout. Subjects consume twice daily, 1.5 oz whole, natural almonds (Active Condition) or low-fat foods high in refined starches and added sugars, matched for energy content to the almonds (Control Condition). The assigned study products will be dispensed with instructions to consume 2 servings (Active Product) or 3 servings (Control Products) each day, starting on day 1. Subjects will be screened for prediabetes at the first screening visits. An intravenous glucose tolerance test (IVGTT) will be completed at baseline and the end of each treatment period. Fasting blood samples will be collected for lipid profile and high-sensitivity C-reactive protein (hs-CRP) measurements at all visits. Additionally, blood will be drawn for measurement of Apolipoprotein B and A1, lipoprotein particles and subfractions, Interleukin 6 (IL-6) and Uric acid at the beginning and the end of each test period. Assessments of vital signs, body weight, evaluation of inclusion and exclusion criteria, medication/supplement use, and adverse effects will be performed throughout the study. Compliance will be assessed through a daily log record, and return of unopened study product. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03126981
Study type	Interventional
Source	Midwest Center for Metabolic and Cardiovascular Research
Contact
Status	Completed
Phase	N/A
Start date	April 20, 2017
Completion date	September 26, 2018

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05354245` - Using a Complex Carbohydrate Mixture to Steer Fermentation and Improve Metabolism in Adults With Overweight and Prediabetes (DISTAL)	N/A
Completed	`NCT03644524` - Heat Therapy and Cardiometabolic Health in Obese Women	N/A
Recruiting	`NCT06007404` - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting	`NCT06115265` - Ketogenic Diet and Diabetes Demonstration Project	N/A
Completed	`NCT03188263` - Morning Light Treatment to Improve Glucose Metabolism	N/A
Recruiting	`NCT03821961` - 18F-FDOPA PET/CT Imaging in Patients Undergoing Metabolic Surgery	N/A
Completed	`NCT04303468` - Intervention With a GABA Supplement in Prediabetics	N/A
Recruiting	`NCT06094231` - Treating Patients With Renal Impairment and Altered Glucose MetAbolism With TherapeutIc Carbohydrate Restriction and Sglt2-Inhibiton - a Pilot Study	N/A
Completed	`NCT03675360` - Low-Carbohydrate Dietary Pattern on Glycemic Outcomes Trial	N/A
Completed	`NCT01910051` - Explorative Assessment of Biomarkers in Overweight and Obese Subjects
Completed	`NCT03527368` - The Time-Restricted Intake of Meals Study	N/A
Not yet recruiting	`NCT06453278` - (DDS) in India: a Screening Tool to Identify Prediabetes and Undiagnosed Type 2 Diabetes in Dental Settings
Completed	`NCT02899390` - Diabetes Prevention Program in Adults of the Yaqui Tribe of Hermosillo, Sonora at Risk of Diabetes	N/A
Suspended	`NCT03240978` - Exercise Intervention for the Prevention of Prediabetes in Overweight Chinese	N/A
Completed	`NCT03865342` - Prevention of Diabetes Using Mobile-enabled, Virtual Delivery of the National Diabetes Prevention Program	N/A
Recruiting	`NCT01972113` - Vitamin K and Glucose Metabolism in Children at Risk for Diabetes (Vita-K 'n' Kids Study)	N/A
Completed	`NCT01436916` - Oral Cholecalciferol in Prevention of Type 2 Diabetes Mellitus	Phase 4
Completed	`NCT01432509` - Prospective Follow-up of a Cohort of Pre-diabetics in the North of France (DiabeNord)	N/A
Completed	`NCT00990184` - Study to Evaluate the Effects of Colesevelam on Insulin Sensitivity and ß-Cell Function in Subjects With Impaired Fasting Glucose (Prediabetes)	Phase 3
Completed	`NCT00886340` - A Lifestyle Change Program to Prevent Type 2 Diabetes	Phase 2